Preoperative selection of symptomatic breast cancer patients appropriate for lymphatic mapping and sentinel node biopsy

Irish Journal of Medical Science

Volumn 176, Issue 2, 2007, Pages 91-96

  Barry, Mitchel ^a,b   Cahill, R A ^a   Roche Nagle, G ^a   Landers, R ^a   Walsh, D ^a   Bouchier Hayes, D J ^a   Watson, R G K ^a  

^a WATERFORD REGIONAL HOSPITAL   (Ireland)

^b BEAUMONT HOSPITAL   (Ireland)

Author keywords

Preoperative selection; Sentinel node; Symptomatic breast cancer; Tumour profiling

Indexed keywords

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER GRADING; CANCER PATIENT; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MASTECTOMY; MEDICAL ASSESSMENT; MEDICAL DECISION MAKING; PATIENT SELECTION; PREOPERATIVE EVALUATION; SENTINEL LYMPH NODE BIOPSY; SYMPTOM; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; PATIENT SELECTION; SENTINEL LYMPH NODE BIOPSY;

EID: 34250725479     PISSN: 00211265     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11845-007-0034-x     Document Type: Article

References (25)

1. Blanchard DK, Donohue JH, Reynolds C, Grant CS (2003) Relapse and morbidity in patients undergoing sentinel node biopsy alone or with axillary dissection for breast cancer. Arch Surg 138:482-488
2. Beenkein SW, Urist MM, Zhang Y et al (2003) Axillary lymph node status, but not tumour size, predicts locoregional recurrence and overall survival after mastectomy fro breast cancer. Ann Surg 237(5):732-739
3. Noguchi M (2002) Sentinel node biopsy and breast cancer. Br J Surg 89:21-34
4. Karamlou T, Johnson NM, Chan B, Franzini D, Mahin D (2003) Accuracy of intraoperative touch imprint cytologic analysis of sentinel lymph nodes in breast cancer. Am J Surg 185(5):425-428
5. Mullenix PS, Carter PL, Martin MJ et al (2003) Predictive value of intraoperative touch preparation analysis of sentinel lymph nodes for axillary metastasis in breast cancer. Am J Surg 185(5):420-424
6. Kaufman CS, Jacobson-Kaufman MFT, Thorndike-Christ T, Kaufman L, Tabar L (2001) A treatment scale for axillary management in breast cancer. Am J Surg 182(4):377-383
7. Bevilacqua JLB, Cody HS, MacDonald KA et al (2002) A model for the predicting axillary node metastases based on 2000 sentinel node procedures and tumour position. EJSO 28(5):490-500
8. Alexander FE, Anderson TJ, Hubbard AL (1997) Screening status in relation to biological and chronological characteristics of breast cancers: A cross-sectional survey. J Med Screen 4:152-157
9. Skinner KA, Silberman H, Sposto R, Silverstein MJ (2001) Palpable breast cancers are inherently different from non-palpable breast cancers. Ann Surg Oncol 8:705-710
10. Groenendijk RP, Bult P, Tewarie L et al (2000) Screen detected breast cancers have a lower mitotic activity index. Br J Cancer 82:381-384
11. Bloom HJ, Richardson WW (1957) Histological grading and prognosis in breast cancer. Br J Cancer 11:359-377
12. Scarff RW, Torloni H (1968) Histological typing of breast tumours. In: Sobin LH (ed) International histological classification of tumours, no. 2, vol 2. World Health Organisation, Geneva, pp 13-20
13. Giuliano AE, Kirgan DM, Guenther JM, Morton DL (1994) Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220:391-401
14. Krag DN, Weaver DL, Alex JX, Fairbanks JT (1993) Surgical resection and radiolocalisation of the sentinel node in breast cancer using the gamma probe. Surg Oncol 2:335-340
15. Barth A, Craig PH, Silverstein MJ (1997) Predictors of axillary lymph node metastases in patients with T1 breast carcinoma. Cancer 79:1856-1864
16. Carter CL, Allen C, Henson DE (1989) Relation of tumour size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 63:181-187
17. Holland PA, Wall J, Boggis CRM et al (1996) A comparison of axillary lymph node status between cancers detected at the prevalence and first incidence breast screening rounds. Br J Cancer 74:1643-1646
18. Veronesi U, Paganelli G, Galimberti V et al (1997) Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 349:1864-1867
19. Chadha M, Chabon AB, Friedmann P, Vikram B (1994) Predictors of axillary lymph node metastases in patients with T1 breast cancer. Cancer 73:350-353
20. Olivotto IA, Jackson JSH, Mates D et al (1998) Prediction of axillary lymph node involvement of women with invasive breast carcinoma. Cancer 83:948-955
21. Hieken TJ, Harrison J, Herreros J, Velasco JM (2001) Correlating sonography, mammography, and pathology in the assessment of breast cancer size. Am J Surg 182(4):351-354
22. Groenendijk RP, Bult P, Noppen CM et al (2003) Mitotic activity index in interval breast cancers. Eur J Surg Oncol 29(1):29-31
23. Tubiana M, Koscielny S (1999) The rationale for early diagnosis of cancer-the example of breast cancer. Acta Oncol 38(3):295-303
24. Brenin DR, Manasseh DM, El Tamer M et al (2001) Factors correlating with lymph node metastases in Patients with T1 Breast Cancer. Ann Surg Oncol 8(5):432-437
25. Jakub JW, Ebert MD, Diaz NM et al (2003) Effect of lymphatic mapping on diagnosis and treatment of patients with T1a, T1b favourable breast cancer. Ann Surg 237(6):838-843